These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 15803357

  • 1. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
    Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Köppel H, Wascher TC, Paulweber B, Samonigg H.
    Breast Cancer Res Treat; 2005 Mar; 90(2):113-5. PubMed ID: 15803357
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
    Eder T, Mayer R, Langsenlehner U, Renner W, Krippl P, Wascher TC, Pummer K, Kapp KS.
    Eur J Cancer; 2007 Feb; 43(3):472-5. PubMed ID: 17182240
    [Abstract] [Full Text] [Related]

  • 3. Haplotype-tagging interleukin-10 promoter polymorphism is associated with reduced risk of retinal artery occlusion.
    Weger M, Steinbrugger I, El-Shabrawi Y, Wegscheider BJ, Weger W, Renner W, Schmut O, Haas A.
    Mol Vis; 2007 Apr 04; 13():549-52. PubMed ID: 17438520
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.
    Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y, Zhang L.
    Tissue Antigens; 2007 Jul 04; 70(1):12-7. PubMed ID: 17559576
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study.
    Langsenlehner U, Wolf G, Langsenlehner T, Gerger A, Hofmann G, Clar H, Wascher TC, Paulweber B, Samonigg H, Krippl P, Renner W.
    Breast Cancer Res Treat; 2008 May 04; 109(2):297-304. PubMed ID: 17636397
    [Abstract] [Full Text] [Related]

  • 6. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
    Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 04; 15(6):1148-52. PubMed ID: 16775174
    [Abstract] [Full Text] [Related]

  • 7. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Köppel H, Leithner A, Wascher TC, Paulweber B, Samonigg H.
    Clin Cancer Res; 2004 May 15; 10(10):3518-20. PubMed ID: 15161710
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-10-592C/A, -819C/T and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients.
    Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY.
    Clin Endocrinol (Oxf); 2009 Mar 15; 70(3):401-7. PubMed ID: 18616700
    [Abstract] [Full Text] [Related]

  • 9. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U, Renner W, Yazdani-Biuki B, Eder T, Wascher TC, Paulweber B, Clar H, Hofmann G, Samonigg H, Krippl P.
    Breast Cancer Res Treat; 2006 May 15; 97(1):67-72. PubMed ID: 16317580
    [Abstract] [Full Text] [Related]

  • 10. Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion.
    Zammiti W, Mtiraoui N, Cochery-Nouvellon E, Mahjoub T, Almawi WY, Gris JC.
    Mol Hum Reprod; 2006 Dec 15; 12(12):771-6. PubMed ID: 17041236
    [Abstract] [Full Text] [Related]

  • 11. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS, Lee SJ, Choi JE, Cha SI, Lee EB, Park TI, Kim CH, Lee WK, Kam S, Choi JY, Kang YM, Park RW, Kim IS, Cho YL, Jung TH, Han SB, Park JY.
    Cancer Epidemiol Biomarkers Prev; 2005 Nov 15; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [Abstract] [Full Text] [Related]

  • 12. Genetic variation in interleukin-10 gene and risk of oral cancer.
    Yao JG, Gao LB, Liu YG, Li J, Pang GF.
    Clin Chim Acta; 2008 Feb 15; 388(1-2):84-8. PubMed ID: 17980158
    [Abstract] [Full Text] [Related]

  • 13. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
    Li F, Ren GS, Li HY, Wang XY, Chen L, Li J.
    Clin Oncol (R Coll Radiol); 2009 May 15; 21(4):302-5. PubMed ID: 19138835
    [Abstract] [Full Text] [Related]

  • 14. Association of breast cancer and cytokine gene polymorphism in Turkish women.
    Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, Manavoglu O.
    Saudi Med J; 2007 Nov 15; 28(11):1728-33. PubMed ID: 17965799
    [Abstract] [Full Text] [Related]

  • 15. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.
    Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442
    [Abstract] [Full Text] [Related]

  • 16. Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive disease.
    Blanco E, Moñux G, Mas A, Serrano FJ, de la Concha EG, Urcelay E.
    Hum Immunol; 2008 Oct 15; 69(10):651-4. PubMed ID: 18703105
    [Abstract] [Full Text] [Related]

  • 17. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
    Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B.
    Hum Immunol; 2008 Mar 15; 69(3):179-86. PubMed ID: 18396210
    [Abstract] [Full Text] [Related]

  • 18. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC.
    Am J Gastroenterol; 2009 Nov 15; 104(11):2704-13. PubMed ID: 19603010
    [Abstract] [Full Text] [Related]

  • 19. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, Lin LY.
    Lung Cancer; 2005 Dec 15; 50(3):291-7. PubMed ID: 16122836
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.
    Rosado S, Rua-Figueroa I, Vargas JA, Garcia-Laorden MI, Losada-Fernandez I, Martin-Donaire T, Perez-Chacon G, Rodriguez-Gallego C, Naranjo-Hernandez A, Ojeda-Bruno S, Citores MJ, Perez-Aciego P.
    Int J Immunogenet; 2008 Jun 15; 35(3):235-42. PubMed ID: 18397303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.